Location History:
- Machida, JP (2013)
- Tokyo, JP (2013 - 2020)
Company Filing History:
9 out of 272 
7 out of 432 
1 out of 45 
Years Active: 2013-2020
Title: Innovations of Yoshimasa Inagaki
Introduction
Yoshimasa Inagaki is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of therapeutic antibodies. With a total of 10 patents to his name, Inagaki's work has the potential to impact the treatment of various blood tumors.
Latest Patents
Inagaki's latest patents include an anti-TIM-3 antibody, which is designed to exhibit high antibody-dependent cellular cytotoxicity (ADCC) activity. This invention involves screening monoclonal antibodies that bind to the extracellular region of TIM-3, leading to the development of a therapeutic agent and diagnostic agent. Another notable patent is a method for treating blood tumors using the anti-TIM-3 antibody. This method targets patients with specific blood tumor cell fractions, providing a promising approach to combat diseases such as acute myeloid leukemia (AML) and chronic lymphocytic leukemia (CLL).
Career Highlights
Throughout his career, Inagaki has worked with notable organizations, including Kyowa Hakko Kirin Co., Limited and Kyushu University. His research has focused on the intersection of immunology and oncology, leading to innovative solutions for challenging medical conditions.
Collaborations
Inagaki has collaborated with esteemed colleagues such as Koichi Akashi and Yoshikane Kikushige. These partnerships have fostered a collaborative environment that enhances the development of groundbreaking therapies.
Conclusion
Yoshimasa Inagaki's contributions to the field of biotechnology through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in the treatment of blood tumors and other related diseases.